Ernexa Therapeutics Inc. Gains 40.8%
Wed, Oct 29, 2025 at 07:16 PM
Ernexa Therapeutics Inc. (ERNA:NASDAQ) jumped higher at $1.76, representing a gain of 40.8%. On Wed, Oct 29, 2025, ERNA:NASDAQ touched a New 2-Week High of $1.76. The stock got featured on our News Catalysts scanner on Wed, Oct 29, 2025 at 10:47 AM in the 'PATNERSHIP' category. From Wed, Oct 15, 2025, the stock recorded 50.00% Up Days and 45.45% Green Days
The stock spiked on Wed, Oct 29, 2025 at $2.86 with a volume of 211M+.
About Ernexa Therapeutics Inc. (ERNA:NASDAQ)
Brooklyn ImmunoTherapeutics Inc is a clinical-stage biopharmaceutical company. It is developing IRX-2, a novel hd-IL-2 -based therapy, to treat patients with cancer.
Top 10 Gainers:
- Smart for Life, Inc. (SMFL:NASDAQ), 400%
- Cambium Networks Corporation (CMBM:NASDAQ), 377.35%
- Movella Holdings Inc. (MVLA:NASDAQ), 100%
- Purple Biotech Ltd (PPBT:NASDAQ), 81.69%
- Hempacco Co., Inc. (HPCO:NASDAQ), 80%
- ProPetro Holding Corp. (PUMP:NYSE), 52.05%
- Ernexa Therapeutics Inc. (ERNA:NASDAQ), 40.8%
- Kuke Music Holding Limited (KUKE:NYSE), 39.18%
- Charming Medical Limited (MCTA:NASDAQ), 36.13%
- Texxon Holding Limited (NPT:NASDAQ), 33.89%